Literature DB >> 18030541

Rigorous development does not ensure that guidelines are acceptable to a panel of knowledgeable providers.

Teryl K Nuckols1, Yee-Wei Lim, Barbara O Wynn, Soeren Mattke, Catherine H MacLean, Philip Harber, Robert H Brook, Peggy Wallace, Rena H Garland, Steven Asch.   

Abstract

BACKGROUND: Rigorous guideline development methods are designed to produce recommendations that are relevant to common clinical situations and consistent with evidence and expert understanding, thereby promoting guidelines' acceptability to providers. No studies have examined whether this technical quality consistently leads to acceptability.
OBJECTIVE: To examine the clinical acceptability of guidelines having excellent technical quality. DESIGN AND MEASUREMENTS: We selected guidelines covering several musculoskeletal disorders and meeting 5 basic technical quality criteria, then used the widely accepted AGREE Instrument to evaluate technical quality. Adapting an established modified Delphi method, we assembled a multidisciplinary panel of providers recommended by their specialty societies as leaders in the field. Panelists rated acceptability, including "perceived comprehensiveness" (perceived relevance to common clinical situations) and "perceived validity" (consistency with their understanding of existing evidence and opinions), for ten common condition/therapy pairs pertaining to Surgery, physical therapy, and chiropractic manipulation for lumbar spine, shoulder, and carpal tunnel disorders.
RESULTS: Five guidelines met selection criteria. Their AGREE scores were generally high indicating excellent technical quality. However, panelists found 4 guidelines to be only moderately comprehensive and valid, and a fifth guideline to be invalid overall. Of the topics covered by each guideline, panelists rated 50% to 69% as "comprehensive" and 6% to 50% as "valid".
CONCLUSION: Despite very rigorous development methods compared with guidelines assessed in prior studies, experts felt that these guidelines omitted common clinical situations and contained much content of uncertain validity. Guideline acceptability should be independently and formally evaluated before dissemination.

Entities:  

Mesh:

Year:  2007        PMID: 18030541      PMCID: PMC2173921          DOI: 10.1007/s11606-007-0440-9

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  30 in total

Review 1.  Why don't physicians follow clinical practice guidelines? A framework for improvement.

Authors:  M D Cabana; C S Rand; N R Powe; A W Wu; M H Wilson; P A Abboud; H R Rubin
Journal:  JAMA       Date:  1999-10-20       Impact factor: 56.272

2.  The impact of practice guidelines in the management of Barrett esophagus: a national prospective cohort study of physicians.

Authors:  M Cruz-Correa; C P Gross; M I Canto; M Cabana; R E Sampliner; J P Waring; C McNeil-Solis; N R Powe
Journal:  Arch Intern Med       Date:  2001-11-26

3.  Validity of the Agency for Healthcare Research and Quality clinical practice guidelines: how quickly do guidelines become outdated?

Authors:  P G Shekelle; E Ortiz; S Rhodes; S C Morton; M P Eccles; J M Grimshaw; S H Woolf
Journal:  JAMA       Date:  2001-09-26       Impact factor: 56.272

Review 4.  A review of quantitative studies of adherence to mental health clinical practice guidelines.

Authors:  Mark S Bauer
Journal:  Harv Rev Psychiatry       Date:  2002 May-Jun       Impact factor: 3.732

5.  Physician knowledge, attitudes and practices regarding a widely implemented guideline.

Authors:  Marcia M Ward; Thomas E Vaughn; Tanya Uden-Holman; Bradley N Doebbeling; William R Clarke; Robert F Woolson
Journal:  J Eval Clin Pract       Date:  2002-05       Impact factor: 2.431

6.  Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project.

Authors: 
Journal:  Qual Saf Health Care       Date:  2003-02

7.  Characteristics of effective clinical guidelines for general practice.

Authors:  Jako S Burgers; Richard P T M Grol; Joost O M Zaat; Teun H Spies; Akke K van der Bij; Henk G A Mokkink
Journal:  Br J Gen Pract       Date:  2003-01       Impact factor: 5.386

Review 8.  Conflict between guideline methodologic quality and recommendation validity: a potential problem for practitioners.

Authors:  Joseph Watine; Bruno Friedberg; Eva Nagy; Rita Onody; Wytze Oosterhuis; Peter S Bunting; Jean-Christophe Charet; Andrea Rita Horvath
Journal:  Clin Chem       Date:  2006-01       Impact factor: 8.327

9.  Physician explanations for failing to comply with "best practices".

Authors:  C Mottur-Pilson; V Snow; K Bartlett
Journal:  Eff Clin Pract       Date:  2001 Sep-Oct

10.  Clinical practice guidelines: towards better quality guidelines and increased international collaboration.

Authors:  R Grol; F A Cluzeau; J S Burgers
Journal:  Br J Cancer       Date:  2003-08       Impact factor: 7.640

View more
  14 in total

1.  [General practitioners' guideline for palliative care. A survey of guideline acceptance in quality circles of primary medical care].

Authors:  Ingrid Schubert; Lothar Heymans; Joachim Fessler
Journal:  Med Klin (Munich)       Date:  2010-03-28

Review 2.  AGREE II: advancing guideline development, reporting and evaluation in health care.

Authors:  Melissa C Brouwers; Michelle E Kho; George P Browman; Jako S Burgers; Francoise Cluzeau; Gene Feder; Béatrice Fervers; Ian D Graham; Jeremy Grimshaw; Steven E Hanna; Peter Littlejohns; Julie Makarski; Louise Zitzelsberger
Journal:  CMAJ       Date:  2010-07-05       Impact factor: 8.262

Review 3.  Clinical practice guidelines to inform evidence-based clinical practice.

Authors:  J Stuart Wolf; Heddy Hubbard; Martha M Faraday; John B Forrest
Journal:  World J Urol       Date:  2011-02-18       Impact factor: 4.226

4.  Clarity and applicability of drug-drug interaction management guidelines: a systematic appraisal by general practitioners and community pharmacists in the Netherlands.

Authors:  Annemieke Floor-Schreudering; Peter A G M De Smet; Henk Buurma; Sonia Amini; Marcel L Bouvy
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

Review 5.  Clinical and public health implications of emerging genetic technologies.

Authors:  Anne-Marie Laberge; Wylie Burke
Journal:  Semin Nephrol       Date:  2010-03       Impact factor: 5.299

6.  Is it time to develop AGREE III?

Authors:  Joseph Watine
Journal:  CMAJ       Date:  2019-10-28       Impact factor: 8.262

7.  Barriers to physician adherence to nonsteroidal anti-inflammatory drug guidelines: a qualitative study.

Authors:  J M Cavazos; A D Naik; A Woofter; N S Abraham
Journal:  Aliment Pharmacol Ther       Date:  2008-09-15       Impact factor: 8.171

8.  How can we improve guideline use? A conceptual framework of implementability.

Authors:  Anna R Gagliardi; Melissa C Brouwers; Valerie A Palda; Louise Lemieux-Charles; Jeremy M Grimshaw
Journal:  Implement Sci       Date:  2011-03-22       Impact factor: 7.327

9.  An exploration of how guideline developer capacity and guideline implementability influence implementation and adoption: study protocol.

Authors:  Anna R Gagliardi; Melissa C Brouwers; Valerie A Palda; Louise Lemieux-Charles; Jeremy M Grimshaw
Journal:  Implement Sci       Date:  2009-07-02       Impact factor: 7.327

Review 10.  Appraisal tools for clinical practice guidelines: a systematic review.

Authors:  Ulrich Siering; Michaela Eikermann; Elke Hausner; Wiebke Hoffmann-Eßer; Edmund A Neugebauer
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.